This is a Clinical Study to Assess Whether the Combination of SJ733 and Tafenoquine Will be a Safe and Rapidly Acting Anti-malarial for the Radical Cure of P. Vivax Malaria
Clinical trial NCT07430592 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07430592
- Sponsor
- R. Kiplin Guy
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-10-01
- Primary completion
- 2028-11-20
- Enrollment
- 104
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.